|
Apr 4
|
Bausch + Lomb's Q1 Earnings Expected in Line With Forecasts, RBC says
|
|
Apr 2
|
Patient Voices Highlight the Realities of Living with Irritable Bowel Syndrome During IBS Awareness Month
|
|
Mar 31
|
Bausch + Lomb recalls Envista intraocular lenses over safety risks
|
|
Mar 15
|
Bausch Health announces next steps in financining initiative
|
|
Mar 14
|
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
|
|
Feb 21
|
3 US Growth Companies With Up To 28% Insider Ownership
|
|
Feb 21
|
Why Bausch Health Companies Inc. (BHC) Went Up On Thursday?
|
|
Feb 20
|
Bausch Health Beats on Q4 Earnings and Revenues, Xifaxan Boosts Sales
|
|
Feb 20
|
Q4 2024 Bausch + Lomb Corp Earnings Call
|
|
Feb 20
|
Compared to Estimates, Bausch (BHC) Q4 Earnings: A Look at Key Metrics
|
|
Feb 20
|
Bausch Health (BHC) Q4 Earnings and Revenues Top Estimates
|
|
Feb 19
|
Bausch: Q4 Earnings Snapshot
|
|
Feb 19
|
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
|
|
Feb 19
|
Bausch + Lomb (BLCO) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Feb 19
|
Bausch and Lomb's dealmaking CEO Brent Saunders: No deal for company is imminent
|
|
Feb 19
|
Bausch + Lomb (BLCO) Surpasses Q4 Earnings and Revenue Estimates
|
|
Feb 19
|
Bausch + Lomb to shake up contact lenses with deal off the table
|
|
Feb 19
|
Bausch + Lomb Higher in U.S. Pre-market After Posting Increase in Q4 Adjusted Profit, Revenue
|
|
Feb 19
|
Bausch + Lomb’s (NYSE:BLCO) Q4: Beats On Revenue
|
|
Feb 19
|
Bausch + Lomb: Q4 Earnings Snapshot
|